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abstract
 
Dihydropyridines (DHPs) are well known for their effects on L-type voltage-dependent Ca
 
2
 
1
 
 chan-
 
nels. However, these drugs also affect other voltage-dependent ion channels, including 
 
Shaker
 
 K
 
1
 
 channels. We ex-
amined the effects of DHPs on the 
 
Shaker
 
 K
 
1
 
 channels expressed in 
 
Xenopus
 
 oocytes. Intracellular applications of
DHPs quickly and reversibly induced apparent inactivation in the 
 
Shaker
 
 K
 
1
 
 mutant channels with disrupted
N- and C-type inactivation. We found that DHPs interact with the open state of the channel as evidenced by the
decreased mean open time. The DHPs effects are voltage-dependent, becoming more effective with hyperpolar-
ization. A model which involves binding of two DHP molecules to the channel is consistent with the results ob-
tained in our experiments.
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introduction
 
Dihydropyridines (DHPs)
 
1
 
 with a 1,4 dihydropyridine
ring and a phenyl ring are clinically used to treat a vari-
ety of cardiovascular disorders, primarily acting as va-
sodilators. Effects of the DHPs on L-type Ca
 
2
 
1
 
 channels
are especially interesting in that the DHPs can be ei-
ther agonists or antagonists (Reuter et al., 1988; Hess,
1990). These drugs appear to act allosterically to mod-
ify the channel function by promoting different modes
of gating (Hess, 1990). They have greater affinities for
the inactivated state of the channel, which is favored by
depolarization (Hess, 1990).
Although DHPs have profound effects on L-type Ca
 
2
 
1
 
channels, it was shown that these compounds also af-
fected voltage-dependent Na
 
1
 
 channels (Yatani et al.,
1988) and voltage-dependent K
 
1
 
 channels (Jacobs and
DeCoursey, 1990; Gotoh et al., 1991). Using the whole
cell voltage-clamp method, Jacobs and DeCoursey (1990)
tested a series of clinically relevant agents, including
nifedipine, on the K
 
1
 
 currents in alveolar epithelial
cells and found that nifedipine produced apparent in-
activation. They suggested that nifedipine, at least in
part, works by acting as an open channel blocker. Go-
toh et al. (1991) studied the effect of nicardipine on the
K
 
1
 
 channel current in rabbit heart cells. They found
that nicardipine accelerated the time course of the out-
ward K
 
1
 
 current decline with the 50% inhibitory con-
centration of 630 nM. This is fourfold higher than that
for the Ca
 
2
 
1
 
 current in the same cells (160 nM).
The structural elements involved in the DHP binding
to the Ca
 
2
 
1
 
 channels are not thoroughly understood.
Biochemical experiments (Nakayama et al., 1991; Reg-
ulla et al., 1991) using antibody mapping indicated that
DHPs may bind to the amino acid residues in the S6
segment of the 
 
a
 
1
 
 subunit of the Ca
 
2
 
1
 
 channel. Some
investigators (Glossmann et al., 1984; Triggle et al.,
1989) have suggested that Ca
 
2
 
1
 
 channels may have two
DHP binding sites, a high-affinity site (nM range) and a
low-affinity site (
 
m
 
M range). A mutagenesis study using
chimeric channels based on two distinct Ca
 
2
 
1
 
 channels
with different DHP affinities shows that the S5, Pore,
and S6 segments may be important in determining the
DHP sensitivity (Grabner et al., 1996). A molecular sim-
ulation study showing how a DHP may bind to the Ca
 
2
 
1
 
channel pore with Ca
 
2
 
1
 
 ions bound suggests that DHPs
occlude the channel pore (Zhorov and Ananthanaray-
anan, 1996).
We investigated the effects of DHPs on the 
 
Shaker
 
 K
 
1
 
channels expressed in 
 
Xenopus
 
 oocytes. Native cells may
express more than one class of K
 
1
 
 channels and the in-
terpretations of the results of the drug action are usu-
ally not straightforward. Heterologous expression of a
single class of channel can largely overcome this prob-
lem. Since the biophysical gating properties of the
 
Shaker
 
 channel have been studied extensively (Bezanilla
et al., 1994; Hoshi et al., 1994; Stefani et al., 1994; Zag-
otta et al., 1994
 
a,b
 
), any alterations in the channel gat-
ing can be more easily detected and studied. Further-
more, molecular manipulations of the 
 
Shaker
 
 channel
affecting some of the gating transitions, such as inacti-
vation rates, have been described (Hoshi et al., 1990,
1991; Zagotta et al., 1990; Lopez-Barneo et al., 1993),
and they can be used to probe the interactions of the
channel with DHPs. The results obtained in this study
indicate that DHPs interact with the open state of the
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Shaker
 
 channel inducing apparent inactivation although
the drugs do not act as simple open-channel blockers.
The results also show that the overall DHP efficacy can
be modulated by a single amino acid mutation in the
S6 segment.
 
materials and methods
 
Channel Expression
 
Wild-type and mutant 
 
Shaker
 
 K
 
1
 
 channels were expressed in 
 
Xeno-
pus
 
 oocytes essentially as described previously (Hoshi et al.,
1990). The following channels were used in this study. 
 
Sh
 
D (Timpe
et al., 1988) is characterized by intact N-type inactivation and
C-type inactivation. 
 
Sh
 
B
 
D
 
6-46 contains a 41-residue deletion in
the amino terminus and lacks N-type inactivation (Hoshi et al.,
1990). In addition to the amino terminus deletion, 
 
Sh
 
B
 
D
 
6-46
T449V contains a single amino acid substitution at position 449
(using the 
 
Sh
 
B numbering) from T to V. The 
 
Sh
 
B
 
D
 
6-46 T449V
channel has disrupted N-type inactivation and drastically slowed
or disrupted C-type inactivation (Lopez-Barneo et al., 1993).
 
Sh
 
B
 
D
 
6-46 T449K has a point mutation at position 449 from T to
K to accelerate C-type inactivation to a more experimentally man-
ageable range (Lopez-Barneo et al., 1993). 
 
Sh
 
B
 
D
 
6-46 T449V:
A463I has an additional point mutation at position 463 that has
been shown to be involved in C-type inactivation (Hoshi et al.,
1991). The RNAs were transcribed using T7 RNA polymerase
(Ambion, Austin, TX) and injected into the oocytes (40 nl/cell).
Recordings were typically made 1 to 14 d after injection.
 
Electrophysiological Recording
 
In most experiments, the single channel and macroscopic patch
currents were recorded using excised configurations of the patch-
clamp technique (Hamill et al., 1981; Methfessel et al., 1986)
with an AxoPatch 200A amplifier (Axon instruments, Foster City,
CA). The macroscopic patch currents were low-pass filtered
through an eight-pole Bessel filter unit with 2 kHz corner fre-
quency (Frequency Devices, Haverhill, MA) and digitized at 10
kHz using an ITC16 computer interface (Instrutech, Great Neck,
NY). The whole oocyte currents were recorded using a Warner
OC-725B (Warner, Hamden, CT) two-electrode voltage clamp
amplifier. The electrodes filled with 3 M KCl had a typical resis-
tance of less than 0.5 M
 
V
 
. The data were collected and analyzed
using Pulse/PulseFit (HEKA, Lambrecht, Germany), IGOR PRO
(Wavemetrics, Lake Oswego, OR), TAC (SKALAR, Seattle, WA),
and DataDesk (DataDescriptions, Ithaca, NY) programs running
on Apple Macintosh computers. Unless otherwise indicated, the
linear capacitative and leak currents have been subtracted from
the macroscopic currents presented using a modified P/n proto-
col. The single channel data were idealized using the half ampli-
tude threshold method. For the analysis of the single channel
dwell times, additional exponential components were included
only if the probability of requiring one additional component
was 
 
.
 
0.95 using the likelihood ratio test (Hoshi et al., 1994). Nu-
merical simulations of the ionic currents predicted by the kinetic
schemes were performed using the Q-matrix approach (Colqu-
houn and Hawkes, 1995) implemented in IGOR. The parameters
of the schemes were optimized by minimizing the chi-squared
value using the downhill simplex algorithm (Press et al., 1994)
implemented in IGOR. When appropriate, the data values are
presented as mean 
 
6
 
 standard deviation. The error bars are not
shown when smaller than the symbol size. All experiments were
performed at room temperature (20–24
 
8
 
C).
 
Solutions
 
The intracellular solution typically contained (in mM): 140 KCl,
11 EGTA, 10 HEPES, pH 7.2 (titrated with 
 
n
 
-methyl-
 
d
 
-glucamine
[NMG]). The extracellular solution typically contained (in mM):
140 NaCl, 2 MgCl
 
2
 
, 2 KCl, 10 HEPES (NMG), pH 7.2. The high
K
 
1
 
 extracellular solution contained (in mM): 140 KCl, 2 MgCl
 
2
 
,
10 HEPES (NMG), pH 7.2. Other solutions used are indicated in
the legends.
Nifedipine (Sigma Chemical Co., St. Louis, MO), Bay K 8644
(RBI, Natick, MA), and nimodipine (Sigma) were dissolved in
100% ethanol (10 mM). Nicardipine (Sigma) was dissolved in
100% methanol (5 mM). The stock solutions were kept in the
dark at 
 
,
 
4
 
8
 
C. The drug solutions were prepared fresh from these
stock solutions and vortexed immediately before each use.
 
results
 
The 
 
Sh
 
B
 
D
 
6-46 T449V channel contains a deletion in
the amino terminus to disrupt N-type inactivation
(Hoshi et al., 1990). In addition, threonine at position
449 (in 
 
Sh
 
B numbering) in the P-segment is mutated to
valine to disrupt or drastically slow C-type inactivation
(Lopez-Barneo et al., 1993). Effects of DHPs were pri-
marily assayed using this 
 
Sh
 
B
 
D
 
6-46 T449V channel since
the gating transitions are simplified with the N- and
C-type inactivation mechanisms disrupted. Because in-
ternal Mg
 
2
 
1
 
 ions are known to induce voltage-depen-
dent block of currents through 
 
Shaker
 
-like potassium
channels (Ludewig et al., 1993), all data presented were
recorded in the absence of internal Mg
 
2
 
1
 
 ions to ex-
clude interference with divalent block in interpreting
the DHP effects.
 
Nifedipine Induces Apparent Inactivation
 
Application of nifedipine to the intracellular side in-
duced a time-dependent decline in the ionic currents
through the 
 
Sh
 
B
 
D
 
6-46 T449V channels. Fig. 1 
 
A
 
 shows
the effects of intracellular nifedipine (50 
 
m
 
M) on the
 
Sh
 
B
 
D
 
6-46 T449V K
 
1
 
 currents elicited in response to de-
polarizing voltage pulses. The amplitudes of the control
 
Sh
 
B
 
D
 
6-46 T449V currents did not decline appreciably
with maintained depolarization. Most of the reduction
in the control current amplitude observed with main-
tained depolarization is attributable to accumulation of
K
 
1
 
 ions in the extracellular space immediately adjacent
to the channels as judged by the changes in the reversal
potential of the tail currents with time (data not shown).
In the presence of nifedipine, the currents underwent
marked apparent inactivation at the positive voltages
where the activation process is fast, suggesting that nife-
dipine exerts its action after the channel opens. The
current-voltage (I-V) curves indicate that the reduction
of the current amplitude by nifedipine is apparently
voltage dependent (Fig. 1 
 
B
 
).
The effect of nifedipine application to the intracellu-
lar side to induce apparent inactivation had a very fast
onset, much faster than the limit of the manual bath 
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perfusion system employed. The effect was readily and
fully reversible. Applications of nifedipine to the extracel-
lular side were less effective than those to the intracellu-
lar side (Fig. 2 
 
A
 
). Extracellular applications of nifedipine
(100 
 
m
 
M) often induced a time-independent decrease
in the current amplitude (inset traces in Fig. 2 
 
A
 
). These
observations indicate that nifedipine works preferen-
tially from the intracellular side. Considering the non-
polar nature of nifedipine, the effects of extracellular
application were probably mediated by its movement
through the cell membrane.
DHPs are light-sensitive and the effects on voltage-
dependent Ca
 
2
 
1
 
 channels can be markedly diminished
by UV-light (Meyer et al., 1984). We examined whether
the nifedipine effects on the K
 
1
 
 channels could be di-
minished by UV-light. We found that UV-treated nife-
dipine (254 nm, 18 W, for 90 min at 1 cm) was much
less effective in producing the apparent inactivation of
the 
 
Sh
 
B
 
D
 
6-46 T449V currents (Fig. 2 
 
B
 
). The vehicles
(ethanol, methanol) did not induce the inactivation at
the concentrations used.
 
Other Dihydropyridines Are Also Effective
 
In addition to nifedipine, other DHPs are also effective
in inducing apparent inactivation in the 
 
Shaker
 
 channels.
Fig. 3 compares the intracellular applications of nimo-
dipine, nicardipine, and BAY K 8644 (
 
1
 
,
 
2
 
) on the
 
Sh
 
B
 
D
 
6-46 T449V currents elicited in response to the
voltage pulses to 
 
1
 
50 mV. As with nifedipine, these
DHPs induced apparent inactivation in a reversible
manner when applied to the intracellular side. Extra-
Figure 1. Nifedipine block of K1 currents through ShBD6-46
T449V channels. (A) Current traces obtained from the inside-out
patch in response to voltage steps from 2100 mV to 220 mV, 0
mV, and 150 mV with (bottom) and without (top) nifedipine (50
mM) in the internal solution are shown. (B) Current amplitudes
measured at the end of 200-ms pulses with (closed circles) and with-
out (open circles) nifedipine (50 mM) in the internal solution.
Figure 2. (A) Nifedipine applied externally is less effective in
blocking the ionic currents through the ShBD6-46 T449V channel.
Peak amplitudes of the currents measured using the two-electrode
voltage clamp during voltage pulses from 2100 mV to 150 mV are
plotted (filled circles: data measured during nifedipine (100 mM)
application, open circles: wash out of drug). Representative current
sweeps recorded at the end of the corresponding segment are
shown in inset. (B) Nifedipine, exposed to ultraviolet light, is less
effective in blocking the ShBD6-46 T449V current. Representative
inside-out macro-patch currents in response to pulses from 2100
mV to 150 mV. A half of the nifedipine solution (50 mM) was
treated with UV light (254 nm 18W for 90 min at 1 cm) and the ef-
ficacy of the UV-treated nifedipine was compared with the other
half of the nifedipine solution, which did not receive UV treatment. 172 Dihydropyridine Action on Potassium Channels
cellular applications of these drugs were also much less
effective (data not shown). 
Concentration Dependence of DHP Block
The currents recorded at 150 mV in the presence of
various concentrations of nifedipine are shown in Fig. 4
A. Fig. 4 C–F show the concentration dependence of
the block of the macroscopic currents at 150 mV by
nifedipine and nimodipine. The effect of nifedipine at
150 mV became noticeable at 3 mM with the half-maxi-
mal reduction in the steady-state current occurring at
z30 mM (Fig. 4 C). For nimodipine, the half-maximal
reduction was observed at a slightly lower concentration
(Fig. 4 E). With greater concentrations, the apparent
inactivation time course became faster and the steady-
state current became progressively smaller. These re-
sults are again consistent with the drugs exerting the
action after the channel opens. The fractions of the
currents blocked at the end of the sweep are shown in
Fig. 4 C (nifedipine) and E (nimodipine). The time
constants of the current decline are shown in Fig. 4 D
(nifedipine) and F (nimodipine). These plots illustrate
a slight difference in the efficacies of nifedipine and ni-
modipine. The Hill plot transformations of the block
data (Fig. 4 B) indicate that the concentration depen-
dence of both nifedipine and nimodipine block has the
Hill coefficient of 1.5, consistent with more than one
DHP molecule binding to the channel.
Nifedipine Decreases the Mean Open Time
If nifedipine interacts with the open state of the chan-
nel, the mean open time should decrease in a concen-
tration-dependent manner. To examine the effect of
nifedipine on the single channel level, a mutant Shaker
channel, ShBD6-46 T449V:A463I, which contains a sin-
gle amino acid substitution at position 463 (Hoshi et al.,
1991) in the ShBD6-46 T449V background was used. The
A463I mutation increases the single channel amplitude
by 50%, and it increases the mean open time by 20–30-
fold. Thus, this channel is well suited to assay the DHP
effects. Representative openings of a single ShBD6-46
T449V:A463I channel recorded at 0 mV are shown in
Fig. 5 A. Application of nifedipine decreased the mean
open time in a concentration-dependent manner (Fig.
Figure 3. Block of the ShBD6-46 T449V macroscopic currents by
different DHPs. Currents were recorded in the inside-out configu-
ration in response to depolarizing voltage steps to 0 mV. Indicated
DHPs were applied to the internal side. The concentration was 100
mM for all DHPs.
Figure 4. Concentration dependence of DHP block of the mac-
roscopic currents through the ShBD6-46 T449V channels. (A) Cur-
rent traces obtained in response to voltage steps to 150 mV with
the indicated concentrations of nifedipine in the internal solution.
(B) Hill plot of the concentration dependence of block of ShBD6-
46 T449V channel by nimodipine (open circles) and nifedipine
(closed circles). Block is given by Idrug/Icontrol. Dashed lines are the
least square fits of the data with Hill equation. Both nifedipine and
nimodipine fits give a Hill coefficient value of 1.5. (C) Relative re-
duction of the steady state current measured at the end of a 200-
ms voltage pulse to 150 mV by different concentrations of nife-
dipine. Values on the vertical axis were calculated as 1-Inifedipine/
Icontrol. Data points represent mean 6 standard deviation of six ex-
periments. (D) Time constants of the current decline induced by
nifedipine block. The currents elicited by 200-ms voltage pulses to
150 mV in the presence of nifedipine at the concentrations indi-
cated were fitted with a sum of two exponentials. (E) Relative re-
duction of the steady-state current by nimodipine. The data were
collected and analyzed as in C. (F) Time constants of the current
decline in the presence of nimodipine (averages of four to seven
experiments). The data were collected and analyzed as in D. In B–F,
smooth curves show least square fits of the data obtained from the
simulated currents as described in discussion (thin line, scheme ii,
thick line, scheme v).173 Avdonin et al.
5, B and C). The reduction of mean open time is consis-
tent with nifedipine interacting with the open state of
the channel. The amplitude of the main conductance
state of the channel was not markedly affected by nife-
dipine application. Although we observed the substates
more frequently in the presence of nifedipine, we did
not systematically investigate this issue.
The closed durations recorded from the data shown
in Fig. 5 are compared in Fig. 6. In the absence of the
drug, the closed durations were described by a sum of
at least three exponentials. The shortest exponential
component with a time constant value of 200–300 ms
reflects the short burst closures as observed for the
ShBD6-46 channel, Cf (Hoshi et al., 1994). The second
component with a time constant value of 2–4 ms re-
flects the intermediate closed state, Ci (Hoshi et al., 1994).
In addition to these closed duration components, simi-
lar to those already documented for the ShBD6-46 (Hoshi
et al., 1994), the closed durations from the ShBD6-46
T449V:A463I channel also showed an additional com-
ponent with a time constant value of 50–200 ms with a
small fractional amplitude (3% in the data shown).
Nifedipine (100 mM) did not introduce an additional
closed duration component in a statistically significant
way but noticeably increased the relative amplitude of
the third component (from 3% to 11% in Fig. 6). It is
possible that nifedipine did induce an extra compo-
nent, but the new time constant was too similar to one
of the existing time constants to be detected. Similar re-
sults were obtained from two other single-channel
patches.
Interaction between the Nifedipine Block and N- and 
C-type Inactivation
Since nifedipine induces apparent inactivation, we stud-
ied whether nifedipine interacts with N-type or C-type
inactivation. We first examined the possible interaction
between nifedipine and the N-type inactivation mecha-
nism by using the ShD channel (Timpe et al., 1988),
Figure 5. Nifedipine decreases the mean open time in ShBD6-46
T449V:A463I. (A) Representative openings in the absence (upper
traces) and in presence of 100 mM nifedipine (lower traces) in the in-
ternal solution. Inside-out configuration at 0 mV. Closed state is in-
dicated by dashed line. The data were filtered at 1.8 kHz. The
patch contained one functional channel. (B) Open time histo-
grams with and without 100 mM nifedipine. Data are shown in
square root scaling on vertical axis (Sigworth and Sine, 1987). Sin-
gle exponential fits are shown superimposed. (C) Reciprocals of
the mean open times at several concentrations of nifedipine. Each
data point represents the mean 6 standard deviation of four to six
experiments. Solid line shows linear least square fit of first three
points.
Figure 6. Nifedipine effects on the closed time distribution of
ShBD6-46 T449V:A463I. Closed time distributions in the absence
(A) and in the presence (B) of 100 mM nifedipine. Data are shown
in square root scaling on vertical axis. Lines shown represent four
exponential fits of the distributions. Under control conditions the
time constants (fractional amplitudes) were 0.2 ms (0.871), 2.1 ms
(0.097), 16.8 ms (0.029), and 352 ms (0.003). For nifedipine, the
three time constants (fractional amplitudes) were 0.2 ms (0.84),
5.7 ms (0.048), and 26 ms (0.109).174 Dihydropyridine Action on Potassium Channels
which exhibits fast N-type inactivation. As described
earlier (Choi et al., 1991), in the presence of internal
tetraethylammonium (TEA) (2 mM), the current de-
cline is slower since the TEA-bound ShD channels can-
not undergo N-type inactivation, and a cross-over of the
scaled current time courses was observed (Fig. 7 A). In
the absence of TEA, the time course of the current de-
cline was well fitted by a single exponential with a time
constant of 9 ms whereas with TEA, a sum of two expo-
nentials with time constant values of 2 and 26 ms was
required to fit the current decline. In contrast, decline
of the ShD current in the presence of nifedipine was
not slower than the control current and the scaled cur-
rents superimposed well (Fig. 7 B). Because the appar-
ent on and off rates of nifedipine are slower than those
of TEA (see Fig. 1), the results do not necessarily show
that N-type inactivation and nifedipine do not compete.
We further examined whether nifedipine and the
C-type inactivation mechanism compete by using the
ShBD6-46 T449K channel. This channel mutant has a
41–amino acid deletion in the amino terminus to dis-
rupt N-type inactivation (Hoshi et al., 1990). In addi-
tion, it also contains a single amino acid mutation at po-
sition 449 from threonine to lysine to accelerate C-type
inactivation (Lopez-Barneo et al., 1993). If C-type inac-
tivation and nifedipine compete, it is expected that the
time course of the current decline in the presence of
nifedipine is slower because the nifedipine-bound chan-
nels are prevented from undergoing C-type inactiva-
tion. Representative currents through the ShBD6-46
T449K channels in control and in presence of 100 mM
nifedipine are shown in Fig. 7 C and rate constants ob-
tained from two exponential current fits are shown in
Fig. 7 D. In the presence of nifedipine (100 mM), the
current decline was faster than that in the absence of
the drug. The results suggest that nifedipine and C-type
inactivation do not compete.
If nifedipine induces the apparent inactivation in the
ShBD6-46 T449V channel by enhancing the residual
C-type inactivation mechanism, the nifedipine-induced
inactivation should display properties similar to those of
C-type inactivation. For example, the nifedipine-induced
inactivation should slow down in the presence of high
external K1 as C-type inactivation is slowed by high ex-
ternal K1 (Lopez-Barneo et al., 1993). We tested this
hypothesis by comparing the efficacies of the nife-
dipine block in the presence of different external K1
concentrations. As compared in Fig. 7 E, the time
course of the nifedipine block with 140 mM external
K1 was not slower than that observed with 2 or 50 mM
external K1. Thus, the nifedipine-induced inactivation
and C-type inactivation differ in their sensitivities to ex-
ternal K1, suggesting that they are mediated by distinct
mechanisms. This does not, however, rule out the pos-
sibility that nifedipine and C-type inactivation interact
as suggested by the results obtained with the ShBD6-46
T449K channel (Fig. 7, C and D). 
Voltage Dependence of the DHP Block
Because nifedipine is not a charged molecule, it was
not expected that its action would be voltage depen-
dent even if it might position itself in the membrane
electric field. We examined the possible voltage depen-
dence of the DHP action as shown in Fig. 8. The chan-
nels were opened first in response to a voltage pulse to
150 mV to allow the nifedipine molecules to block the
channels. Then, the membrane voltage was changed to
a variety of voltages where the steady-state probability
of the channel being open is still saturated (Zagotta et
al., 1994a). If the DHP action is voltage independent,
the only instantaneous and time-independent changes
in the current, reflecting the changes in the driving
Figure 7. Nifedipine block in presence of either N- or C-type in-
activation. (A) Internal TEA and N-type inactivation compete. The
ShD currents obtained with and without internal TEA (2 mM) are
shown at the top and the scaled currents are shown below. The
scaled currents show a cross-over. (B) Nifedipine block of the mac-
roscopic currents through ShD channels. (C) Macroscopic cur-
rents through the ShBD6-46 T449K channels with C-type inactiva-
tion (control and 100 mM nifedipine). Scaled currents (lower
traces) show that the current in the presence of nifedipine inacti-
vates faster. (D) Time constants of ShBD6-46 T449K current de-
cline in control and in the presence of 100 mM nifedipine in inter-
nal solution. The current traces were fitted with a sum of two expo-
nentials. Each point represents mean 6 standard deviation of 12
experiments (Control) or 8 experiments (Nifedipine). (E) Nifedipine
block (50 mM) of the ShBD6-46 T449V currents without N- or
C-type inactivation recorded with different external K1 concentra-
tions. The currents were elicited by depolarizing pulses to 150 mV. 175 Avdonin et al.
force, should be observed, as recorded under control
conditions (Fig. 8 A). The presence of the time-depen-
dent relaxation of the current would suggest that the
drug action is voltage dependent. The results in Fig. 8,
B–D do show such time-dependent relaxation. The
time courses of the current relaxations were fitted with
single exponentials and the ratios of the extrapolated
instantaneous current amplitudes to the steady state
currents are shown in Fig. 8 E. DHPs became less effec-
tive in blocking the current with greater depolariza-
tion. As a data description parameter for the voltage
dependence, we chose the number of apparent equiva-
lent charges (n). The value n was obtained by fitting
the relative block data (Fig. 8 E) with the following
function
where V is membrane voltage, other constants have
their usual meanings. Examples of this fit for 25 and 50
mM of nifedipine block of ShBD6-46 T449V current are
shown in Fig. 8 E as the solid lines. The apparent
charge number is plotted against the DHP concentra-
tion in Fig. 8 F. The voltage dependence increased with
the drug concentration. The data also show a differ-
ence in the voltage dependence of nifedipine and ni-
modipine blocks of the ShBD6-46 T449V currents as
well as a difference in the voltage dependence of nife-
dipine block of the ShBD6-46 T449V current (Fig. 8 F,
circles) and the ShBD6-46 T449V:A463I current (squares).
Nifedipine Interaction with Ion Flow through Channel
The results presented so far suggest that nifedipine in-
teracts with the open state of the channel to impede
the ion flow. One possible mechanism is that nife-
dipine physically occludes the ion conducting pore,
acting as an open channel blocker. Several molecules
have been shown to act as open channel blockers for
voltage-dependent K1 channels, including TEA, and
the  Shaker inactivation peptide (Demo and Yellen, 1991).
If nifedipine acts as an open channel blocker, K1 flux
through the channel should regulate the block efficacy.
The effects of the direction of the net K1 flow on the
nifedipine efficacy are shown in Fig. 9. With 140 mM
K1 outside, the effects of nifedipine on the net inward
and outward currents were measured at 130 mV with 0
mM and 140 mM K1 inside, respectively. The reduction
in the steady state current caused by nifedipine was not
markedly altered by the changes in the net current
flow, suggesting that DHP efficacy is independent of
the direction of the net current flow.
Regulation of Nifedipine Efficacy by Mutation A463I in the 
S6 Segment
Residue 463 in the S6 segment of the ShB channel has
been shown to be involved in regulation of C-type inac-
tivation (Hoshi et al., 1991; Lopez-Barneo et al., 1993).
In ShBD6-46 T449V, where both the N- and C-type inac-
tivation mechanisms are disrupted, mutating the residue
463 from A to I (ShBD6-46 T449V:A463I) causes the
mean open time and the single channel amplitude to
increase (see Fig. 5). Consistent with the slow channel
closing rate, the macroscopic G(V) curve of this chan-
exp n e V   50 – () k T ¤ [] ,
Figure 8. Voltage dependence of DHP block. The currents were
first elicited by voltage pulses to 150 mV followed by voltage steps
to 220 to 190 mV in 10 mV increments. (A) The ShBD6-46 T449V
channels do not show significant relaxation after the voltage
change. (B) Slow relaxations of the macroscopic currents through
the ShBD6-46 T449V channels in presence of 25 mM nimodipine.
The currents relaxed to lower values at voltages more negative
than  150 mV showing more effective block of nimodipine at these
voltages. (C) Same as B in presence of 100 mM nifedipine. (D)
Voltage-dependent relaxation of the ShBD6-46 T449V:A463I cur-
rent with 100 mM nifedipine. (E) Voltage dependence of the block
for ShBD6-46 T449V in the presence of 25 mM (diamonds) and 50
mM (circles) of nifedipine. Relative block was calculated as a ratio of
the current value immediately after the voltage change over the
current value after relaxation based on the single exponential fit of
the current decline. The data sets were fitted with function exp
[n e (V 2 50) / k T] to obtain number of equivalent charges n. (F)
Concentration dependence of the equivalent charges associated
with the voltage dependence of the block obtained as described in
E for nifedipine block of the ShBD6-46 T449V current (circles),
ShBD6-46 T449V:A463I current (squares), and nimodipine block of
ShBD6-46 T449V current (triangles). Solid lines represent the
scheme v predictions of nifedipine (upper line) and nimodipine
(lower line) block equivalent charges. The model predictions were
calculated using the blocking rate constants obtained from the
concentration dependence data shown in Fig. 4. Data points repre-
sent mean 6 standard deviation of five to eight experiments.176 Dihydropyridine Action on Potassium Channels
Figure 9. Nifedipine block does not depend on the current flow
direction. (A) Macroscopic currents through the ShBD6-46 T449V
channels (control and 100 mM nifedipine) at 130 mV. Outward
currents were obtained with 140 mM K1
out / 140 mM K1
in, and the
inward currents with 140 mM K1
out/ no internal K1 (substituted
with NMG). (B) Comparison of nifedipine block (100 mM) at vari-
ous voltages with high K1 (140 mM) inside (circles) and no K1 ions
inside (squares). External K1 concentration was 140 mM in both
cases. Data points show the fraction of unblocked current at the
end of 200-ms voltage pulse to the voltages indicated (mean 6
standard deviation of five experiments).
Figure 10. Differential effects of nifedipine on the ShBD6-46
T449V and ShBD6-46 T449V:A463I channels. (A) Effects of nife-
dipine (100 mM) on the macroscopic currents recorded at 150
mV from ShBD6-46 T449V (top) and ShBD6-46 T449V:A463I (bot-
tom). (B) Comparison of the concentration dependence of nife-
dipine block of the ShBD6-46 T449V (circles) and ShBD6-46 T449V:
A463I (squares) currents. Solid line represents the model predic-
tion of scheme v for ShBD6-46 T449V:A463I. Values of the block
constants of nifedipine for ShBD6-46 T449V were used in simula-
tion. ShBD6-46 T449V:A463I was simulated by stabilizing the open
state in scheme i by 1.3 kcal/mol (see discussion). Each data
point represents mean 6 standard deviation of six to nine experi-
ments. (C) Scaled tail currents obtained at 2100 mV for ShBD6-46
T449V and at 2120 mV for ShBD6-46 T449V:A463I after pulses to
150 mV with 140 mM K1 out. Nifedipine (100 mM) slowed the tail
current in ShBD6-46 T449V and accelerated in ShBD6-46 T449V:
A463I.
nel is shifted to a more negative direction by z40 mV
compared with that of ShBD6-46 or ShBD6-46 T449V
(data not shown). We found that the effects of nife-
dipine on ShBD6-46 T449V:A463I are distinct from those
on ShBD6-46 T449V. The effects of nifedipine on the
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areas: steady-state fraction of the current blocked, re-
covery from the nifedipine block, and voltage depen-
dence of the block. Nifedipine (100 mM) was less effec-
tive in blocking the ShBD6-46 T449V:A463I channel
than the ShBD6-46 T449V channel. Fig. 10 B compares
the concentration dependence of nifedipine block of
the  ShBD6-46 T449V (circles) and ShBD6-46 T449V:
A463I (squares) currents, also showing that nifedipine is
less effective on the ShBD6-46 T449V:A463I channel. A
difference in the voltage dependence of nifedipine
block of these two channel types is shown in Fig. 8 F
using the same symbols.
Nifedipine differentially altered the tail currents
through the ShBD6-46 T449V and ShBD6-46 T449V:
A463I channels. The tail current was slowed by nife-
dipine in the ShBD6-46 T449V channels (Fig. 10 C). In
contrast, nifedipine accelerated the time course of de-
activation in the ShBD6-46 T449V:A463I channel at all
the voltages examined (2100 to 2140 mV).
discussion
The results presented show that DHPs, such as nifedipine
and nimodipine, reduce the ionic currents through the
Shaker K1 channels. Although higher concentrations of
DHPs are required for inhibition of the Shaker channels
than for some voltage-dependent Ca21 channels (Hess,
1990), the DHP effects on the Shaker channels are still
specific and require the intact dihydropyridine struc-
ture since the UV-treated DHPs largely lose their ability
to reduce the current. The DHP efficacy is dependent
on voltage, but independent of the direction of the K1
flow. 
Our consideration of the possible biophysical and
molecular mechanisms underlying the DHP action on
the Shaker channels is based on the description of their
gating process in Zagotta et al. (1994b). This scheme
can be presented in a simplified form as the following: 
where CR represents the numerous closed states that
the channel visits before opening, and Cf represents the
closed state(s) that the channel enters after opening.
At positive voltages, the value of the reverse rate con-
stant b* is small, and the fast transitions between Cf and
O can be assumed to be at equilibrium. This scheme is
well suited for the description of the gating behavior of
ShBD6-46 T449V, which shows neither C- or N-type in-
activation in Xenopus oocytes (Hoshi et al., 1990; Lopez-
Barneo et al., 1993). Although in this scheme, activa-
tion of the channel is represented with a single transi-
tion for simplicity, in numerical simulations we used
the complete model as described in Zagotta et al.
CR OC f
a *
b *
k O  2  Cf
kCf 2 O
(1994b). Values of all the rate constants were taken
from Zagotta et al. (1994b). All the blocking schemes
considered below are based on scheme i as they are re-
duced to this scheme in the absence of drug.
The simplest hypothesis that the DHP molecule binds
to the open conducting state of the channel (O) only
can be represented by the following scheme:
where DHP·O represents the drug-bound non-con-
ducting open state. According to this scheme, the
mean open time should decrease in a concentration-
dependent manner in the presence of nifedipine. The
mean open time was indeed decreased by nifedipine as
shown in Fig. 5. Furthermore, according to scheme ii,
the reciprocal of the mean open time should be lin-
early related to the DHP concentration by the follow-
ing relationship:
assuming that b* 5 0 at positive voltages. This linear
prediction did not hold for all the concentrations of
nifedipine examined (Fig. 5 C). At the high concentra-
tions tested (.40 mM), the block was more than pre-
dicted, raising some implications about the nature of
the block (see below). Furthermore, this model does
not provide any mechanism for the voltage depen-
dence of the block. To improve this model, we could
assume that kon and/or koff in scheme ii are voltage de-
pendent. Alternatively, we can assume that the voltage
dependence of the block comes from a voltage-depen-
dent gating property of the channel rather than volt-
age-dependent binding of the drug. The rate constant
for the Cf to O transition is voltage dependent (Zagotta
et al., 1994b), decreasing with hyperpolarization with
an equivalent charge of 0.17, similar to the voltage de-
pendence of the DHP action (Fig. 8 F). Thus, the fol-
lowing scheme where the DHP molecule binds to the
Cf state from which the exit rate constant g is voltage
dependent could be considered:
DHP•O
CR OC f
a *
b *
k O 2 Cf
kCf 2 O
[DHP]
kon koff
1 topen ¤ () k on DHP [] k O 2 C f + =
DHP•Cf
CR OC f
a *
b *
k O 2 Cf
kCf 2 O
[DHP]
kon koff
(scheme i)
(scheme ii)
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An obvious drawback of this scheme is that it does not
predict the concentration-dependent mean open time.
This can be resolved by combining schemes ii and iii
into a single scheme: 
This model has four more free parameters than
scheme i, and it can account for the effect of DHP on
the mean open time and the voltage dependence of
the block. This model, however, does not describe the
concentration dependence curve well (Fig. 4) and it
predicts a Hill coefficient of 1 as opposed to the ob-
served higher value (Fig. 4 B), which requires binding
of more than one DHP molecules to the channel.
Thus, we introduce the following model:
(scheme v)
Time constants of the current decline, voltage depen-
dence of the block and the concentration dependence
predicted by schemes ii and v were simulated and
shown superimposed on the experimental data (Figs. 4,
8, and 10). For these computations, all parameters in
the absence of drug were fixed at the values given in
Zagotta et al. (1994b). Only the block/unblock rates in-
cluded in each scheme were adjusted by minimizing
the chi square value to simultaneously fit the steady-
DHP•Cf
CR OC f
a *
b *
k O  2 Cf
kCf 2 O
[DHP]
kon koff
DHP•O
[DHP]
kon koff
CR OC f C f (DHP•B)
a*
b*
kO 2 Cf
kCf2O
[DHP]
kA
on kA
off
[DHP]
kA
on kA
off
kB
on
kB
off
[DHP]
kA
on kA
off
[DHP]
O(DHP•A) Cf(DHP•A) Cf(DHP•A)(DHP•B)
kO 2 Cf
kCf2O
kB
on
kB
off
[DHP]
state fractional block (Fig. 4, C and E) and the time
constant of the current decline in the presence of nife-
dipine and nimodipine (Fig. 4, D and F). Table I shows
the parameter values used to simulate the data. The
predictions of scheme v with two DHP binding steps
are markedly better than those of scheme ii with one
binding step (Fig. 4). With the rate constant values ob-
tained from fitting the concentration dependence,
scheme v also reproduces the voltage dependence of
the block even though the parameters were not specifi-
cally optimized to fit the voltage dependence (Fig. 8 F).
The prediction of scheme v about the concentration
dependence of the mean open time, which is deter-
mined by constant kon
A, is consistent with initial slope of
the curve shown in Fig. 5 C. The DHP binding to the
fast closed state Cf in scheme V could also account for
the non-linear concentration dependence of the mean
open time (Fig. 5 C). Because the mean dwell time in
Cf is short, many of the transitions to this state are unre-
solved. The DHP binding to the Cf state will increase its
mean dwell time, thus reducing the number of unre-
solved events, which in turn could result in an apparent
non-linear dependence of the mean open time on
DHP concentration at high concentrations.
The model in scheme v can be used to explain the al-
tered drug sensitivity of the ShBD6-46 T449V:A463I
channel. In the ShBD6-46 T449V:A463I channel, the oc-
cupancy probability in the Cf state is lower than that in
the  ShBD6-46 T449V channel as this channel has a
greater mean open time. Thus, according to scheme v,
where the second DHP molecule binds only to the Cf
state, the ShBD6-46T449V:A463I channel should be less
sensitive to DHP than the ShBD6-46 T449V channel, as
opposed to scheme ii, in which the increased occu-
pancy of the open state should favor increased block-
ing. This prediction is consistent with the data obtained
(see Fig. 10), where ShBD6-46T449V:A463I is less sensi-
tive to DHP. The shift in G(V) curve of the ShBD6-
46T449V:A463I channel could be well represented by
decreasing the rate constants of the transitions away
from the open state (d and O-Cf as given in the model
of Zagotta et al., 1994b) by a factor of 10, thus stabiliz-
ing the open state by z1.3 kcal/mol. The concentra-
tion dependence given by scheme v with the block
rates obtained from the ShBD6-46T449V data with the
open state stabilized by 1.3 kcal/mol is shown in Fig. 10
B. With those values, scheme v produces less block,
which is consistent with the observed effect. We con-
sider the results of the simulations based on scheme v
to be in qualitative agreement with the observed ef-
fects.  scheme v reasonably describes the concentration
and voltage dependence of DHP block as well as the ef-
fect of A463I mutation. There are ways to further in-
crease the agreement between the model prediction
and the experimental data. For example, it is possible
table i
Numerical Values of the Rate Constants Used to Simulate DHP Block
scheme ii scheme v
nifedipine nimodipine nifedipine nimodipine
kon (s21 mM21) 2.42 3.8 — —
koff (s21) 31.9 24.1 — —
kon
A (s21 mM21) — — 0.56 0.72
koff
A (s21) — — 31.9 48.3
kon
B (s21 mM21) — — 49.4 72.2
koff
B (s21) — — 229 109
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to improve the general fit by assuming that allosteric in-
teractions increase the rate of DHP binding to the Cf
(DHP•B) state compared with that to the O state. Since
the available experimental data did not specifically dis-
criminate the various possible allosteric models, we did
not consider them further. 
The observation that DHP is not likely to compete
with C-type inactivation (Fig. 6) suggests that C-type in-
activation itself can occur from the fast closed state,
which is stabilized by the bound DHP molecule. Be-
cause C-type inactivation is slowed by K1 ions (Lopez-
Barneo et al., 1993; Baukrowitz and Yellen, 1996), it is
reasonable to speculate that C-type inactivation occurs
from the fast closed state or other nonconducting states
(Baukrowitz and Yellen, 1996). Baukrowitz and Yellen
(1996) showed that internal TEA derivatives enhance
C-type inactivation by emptying K1 ions from the pore.
Similarly, DHP may have two effects on the Shaker chan-
nel. First, binding of the DHP itself to the channel de-
creases the K1 flux. The reduced K1 ion occupancy in
the channel pore in turn increases the residual C-type
inactivation rate. 
Although a mutation in the S6 segment affected the
DHP efficacy (Fig. 10), it is likely that other amino acid
residues are also involved in regulating the DHP effi-
cacy. For example, considering that DHP preferentially
works from the intracellular side, the residues in the in-
ternal mouth of the channel may also be involved.
Those amino acid residues in the S5, P, and S6 seg-
ments shown to be important for the 4-aminopyridine
block (Kirsch et al., 1993) are also good candidates for
involvement in the DHP sensitivity. However, since the
DHP efficacy does not appear to be markedly influ-
enced by the net K1 flux (Fig. 9), the DHP molecules
probably do not lie directly in the K1 flux pathway.
A large number of dihydropyridines have been syn-
thesized and these drugs appear to have different po-
tencies in blocking the Shaker potassium channel (Fig.
3; unpublished observation). At the same concentra-
tion, nimodipine appears be more effective than nife-
dipine (Fig. 4). However, minor quantitative changes
in the rate constants of the model in scheme v can ac-
count for the observed differential potency, suggesting
that the underlying biophysical mechanisms are the
same. Furthermore, by comparing the effects of differ-
ent dihydropyridines with different side groups, it should
be possible to gain information on which structural
components of the drug are critical in determining the
different rate constants of the model. 
Several mM of nifedipine was required to observe no-
ticeable effects on the ShB channel currents at 150 mV
whereas the drug’s effects on L-type Ca21 channels may
be observed in the nM range. Despite the higher concen-
tration required to affect the Shaker potassium channels,
the effects are specific in that the UV-treated nifedipine
is ineffective. Because the DHP action on Shaker chan-
nels is enhanced by hyperpolarization, it is possible that
the efficacy may be greater under physiological condi-
tions where the transmembrane potential may not reach
150 mV. It is also possible that other homologues of
Shaker channels show much higher DHP sensitivities than
the channels examined in this study. Given the struc-
tural similarities found in different voltage-dependent
ion channels, it will be interesting to rigorously compare
the biophysical and molecular mechanisms of the DHP
action on voltage-dependent Ca21 and K1 channels. 
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